Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?
Ahmet MurtMehmet Rıza AltiparmakSerap YadigarSerkan Feyyaz YalinDogukan OzbeyZeynep YildizBekir KocazeybekMeltem PekpakMuveddet Rezzan AtamanPublished in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2021)
When used in the same dose with the general population, inactivated SARS-CoV-2 vaccines generate reduced humoral response in hemodialysis patients. mRNA vaccines have better immunogenicity in this group.